They would initally require a "modest" number of pills for a short pilot study in people. IF successful a larger proof-of-concept study would follow and IF that's successful, a significantly larger set of pivotal trials. The earliest you might see any approval, given this is an existing drug, is very late this year, likely though Q1/2 2022 - but that will require decisive decision making ie, money and commitment to go for it!
There MAYBE a shorter time-frame a) proof of concept trial and then b) if "a" is successful, then pivotal trials....but I don't know if we have the "in man" use of the drug to support this quicker path....the middle of a pandemic they MIGHT be able to sweet-talk regulators though!!!
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?, page-4
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $94.81M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $156.9K | 801.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 823726 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 347222 | 8 |
View Market Depth
| Last trade - 15.53pm 01/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |